The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. ![]() ![]() While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Any use of this data and information must be determined by the user to be in accordance with applicable federal, state and local laws and regulations.Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Employers should use this information only as a supplement to other information gathered by them and must make independent determination of suitability and completeness of information from all sources to assure proper use of these materials and the safety and health of employees. ![]() This information is furnished without warranty of any kind. The information contained in this section is presented in good faith and believed to be accurate as of the effective date shown above. Labeling and packaging of these products are strictly governed by the EPA with predetermined criteria based on the nature of the product. These formulations undergo detailed EPA review of the chemistry, efficacy and toxicology aspects of the formulation before approval for sale. ![]() Products classified as antimicrobials, such as disinfectants/sanitizers or mold cleaners are subject to registration with the U.S. To comply, we perform safety testing, meet labeling guidelines of regulatory agencies, and adhere to applicable regulations for all ingredients and ingredient formulations that make up our products. and internationally are subject to local, state and federal regulations. All products manufactured and distributed in the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |